CCME Global MD, chairman, board of directors and AGM
BSE: 514336Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹31.81.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹137 Cr2,307th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 14 Aug 2026
- −3.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Aug 2026
- −2.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 May 2026
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day.
- 1,296
CCME Global board of directors
At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- Managing directorPoonam Chaturvedi
- ChairpersonAmi Oza
- Company Secretary and Compliance OfficerMs. Garima Garg
5 directors2 independent1 executive2 non-executive
- Padmanaban KrishnamoorthyNon-executive · joined Jan 2026 · 9 months as independent · 1 listed board · 2 committee seats
- Venkatraman VaralakshmiNon-executive · joined Jan 2026 · 9 months as independent · 1 listed board
- Poonam Chaturvedi · Managing directorExecutive · joined Jan 2026 · 9 months as independent · 1 listed board · 1 committee seat
- Ritika AgrawalIndependent · joined Jan 2026 · 9 months as independent · 1 listed board · 1 as independent · 3 committee seats, 3 as chair
- Ami Oza · ChairpersonIndependent · joined Aug 2026 · 1 month as independent · 1 listed board · 1 as independent · 3 committee seats
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
5 directors who left
- Ashok Chhaganbhai Patel, left 15 Aug 2026: Others
- Balakrishna Koppula, left 19 Jan 2026: Others
- Prasad Rao Kalluri, left 19 Jan 2026: Others
- Mohammed Baba, left 19 Jan 2026: Others
- Vanitha Nagulavari, left 19 Jan 2026: Others
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 29 Aug 20265 of 5 present2 independent · 7 days in between
- 21 Aug 20264 of 4 present1 independent · 6 days in between
- 14 Aug 20265 of 5 present2 independent · 29 days in between
- 15 Jul 20265 of 5 present2 independent · 46 days in between
1 earlier meeting
- 29 May 20265 of 5 present2 independent
Audit Committee
Chair Ritika Agrawal
Poonam Chaturvedi, Ami Oza
- 29 Aug 20263 of 3 present3 independent · 7 days in between
- 21 Aug 20262 of 2 present2 independent · 6 days in between
- 14 Aug 20263 of 3 present3 independent · 29 days in between
- 15 Jul 20263 of 3 present3 independent · 14 days in between
1 earlier meeting
- 30 Jun 20263 of 3 present3 independent
Nomination and remuneration committee
Chair Ritika Agrawal
Padmanaban Krishnamoorthy, Ami Oza
- 29 Aug 20263 of 3 present3 independent · 44 days in between
- 15 Jul 20263 of 3 present3 independent · 97 days in between
- 8 Apr 20262 of 3 present2 independent
Stakeholders Relationship Committee
Chair Ritika Agrawal
Padmanaban Krishnamoorthy, Ami Oza
No meeting listed in the filing.
Preferential Issue Committee
Chair Ritika Agrawal
Ami Oza, Poonam Chaturvedi
- 25 Sep 20263 of 3 present3 independent · 26 days in between
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- M N RAO & ASSOCIATES LLPPeer-review certificate valid to Jan 2028
2 earlier auditors
- M N Rao & AsociatesNamed in the filing for the quarter to Sep 2025
- Ramaswamy Koteswara Rao & Co LLPNamed in the filing for the quarter to Mar 2025
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
CCME Global AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.CCME Global share news and announcements
Annual general meeting, 29 Sep 2026
2,310 shareholders on the register on 22 Sep 2026; present: 2 promoters and 17 others; votes counted by Piyush A Gohel / Piyush A Gohel.The company's voting result (opens in a new tab)
- To consider and adopt the Audited Financial Statement of the Company for thefinancial year 2025 - 2026 together with the Report of the Board of Directors andAuditors thereon.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 84.68% · promoters 100.00% · institutions 0.00% · other public 40.29%
- To appoint a director in place of Mr. Padmanaban Krishnamoorthy (DIN:06830658), who retires by rotation and being eligible, offer himself forreappointment as Director.Ordinary99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.10%
Turnout: all 84.68% · promoters 100.00% · institutions 0.00% · other public 40.29%
To ratify the appointment of M/s Desai Saksena & Associates, Chartered Accountants(FRN: 102358W), as Statutory Auditor to fill the casual vacancy due to resignation ofM/s. M N Rao & Associates LLP (FR No. 005386S/S000195), who hold office up tothis Annual General Meeting of the Company, on such remuneration as may bedecided by the Board of Directors of the Company.MoreLess
Ordinary99.99% for0.01% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.10%
Turnout: all 84.68% · promoters 100.00% · institutions 0.00% · other public 40.29%
- To appoint M/s Desai Saksena & Associates, Chartered Accountants (FRN:102358W), as Statutory Auditor of the Company for the period of 5 (Five) yearsOrdinary99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.10%
Turnout: all 84.68% · promoters 100.00% · institutions 0.00% · other public 40.29%
- To ratify and take note of the revised certificate issued by Chartered Accountantfor change in name of the Company.Ordinary99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.10%
Turnout: all 84.68% · promoters 100.00% · institutions 0.00% · other public 40.29%
- To regularize and approve the appointment of Ms. Ami Oza (DIN: 11385775) asan Independent Non-Executive Director of the Company.Special99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.10%
Turnout: all 84.68% · promoters 100.00% · institutions 0.00% · other public 40.29%
- To approve increase in Authorised Share Capital of the Company consequentialalteration in capital clause of the of the Memorandum of Association of the companyOrdinary99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.10%
Turnout: all 84.68% · promoters 100.00% · institutions 0.00% · other public 40.29%
- To approve offer, issue and allotment of Equity Shares of the Company onPreferential Issue basisSpecial99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.10%
Turnout: all 84.68% · promoters 100.00% · institutions 0.00% · other public 40.29%
- To approve sub-division / split of equity shares of the Company.Ordinary99.98% for0.02% against
Against: promoters 0.00% · institutions 0.00% · other public 0.14%
Turnout: all 84.68% · promoters 100.00% · institutions 0.00% · other public 40.29%
- To approve the transactions with the Company's related partiesOrdinaryPromoters have an interest in it99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.10%
Turnout: all 84.68% · promoters 100.00% · institutions 0.00% · other public 40.29%
- To approve making on investments, giving of loans and provide guaranteeSpecial99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.10%
Turnout: all 84.68% · promoters 100.00% · institutions 0.00% · other public 40.29%
- To grant approval under Section 185 of the Companies Act, 2013 for providingLoan / Guarantee to entities in which Directors of the Company are interested.SpecialPromoters have an interest in it99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.10%
Turnout: all 84.68% · promoters 100.00% · institutions 0.00% · other public 40.29%
- To approve limits for borrowings of the Company under section 180(1)(c) of theCompanies Act, 2013.Special99.98% for0.02% against
Against: promoters 0.00% · institutions 0.00% · other public 0.14%
Turnout: all 84.68% · promoters 100.00% · institutions 0.00% · other public 40.29%
- To authorise the Board of Directors to create security interests over theundertaking or substantially the whole of the undertaking of the Company underSection 180(1)(a) of the Companies Act, 2013.Special99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.10%
Turnout: all 84.68% · promoters 100.00% · institutions 0.00% · other public 40.29%
- To approve shift in registered office of the Company from the State of AndhraPradesh, Eluru to the State of Maharashtra, MumbaiSpecial99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.10%
Turnout: all 84.68% · promoters 100.00% · institutions 0.00% · other public 40.29%
- To approve overall limit for investments by Non-Resident Indians (NRIs) andOverseas Citizens of India (OCIs) in the paid-up equity share capital of theCompany.Special99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.10%
Turnout: all 84.68% · promoters 100.00% · institutions 0.00% · other public 40.29%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Fines
Reported in the filing for the quarter to Sep 2026.
- Fine or penaltyBSE LimitedSince 20 Aug 2026
Non-compliance with requirement to appoint a qualified company secretary as the compliance officer
Delay in appointment of Compliance Officer under Regulation 6 of SEBI LODR Regulations 2015.
In the company's own words, from its latest governance filing.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- No
- The chair is related to the managing director
- No
- The filing has a part on fines and penalties
- Yes
- The filing has a part on tax disputes
- No
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.
How money raised was used
Reported for the quarter to Jun 2026. A preferential issue sells new shares to chosen investors rather than to the public. A warrant or partly paid issue plans the whole issue while the money comes in over time, so the amount set aside can be more than raised so far. A statement's amounts are left out where the raise it states is more than ten times everything the company owns, a figure typed at the wrong scale.
| Raised | Amount raised | For | Set aside | Spent | Spent elsewhere |
|---|---|---|---|---|---|
| Preferential IssuesMar 2026 | – | Expansion of New Business: Investing in setting up new facilities, infrastructure, and equipment to support the FMCG and commodities business. | – | – | No |
| Preferential IssuesMar 2026 | – | Working Capital for New Business: Meeting the working capital requirements for the new import & export business, including inventory, receivables, setting up of office space, and other operational expenses. | – | – | No |
| Preferential IssuesMar 2026 | – | Strategic Investment: Full or part acquisition of global businesses operating in FMCG distribution. | – | – | No |
| Preferential IssuesMar 2026 | – | General Corporate Purpose - Up to 25% (Twenty-five percent) of the Issue Proceeds will be utilised for general corporate purposes, which includes, inter alia, meeting ongoing general corporate exigencies and contingencies, expenses of the Company as applicable in such a manner and proportion as may be decided by the Board from time to time, and/or any other general purposes as may be permissible under applicable laws including SEBI (ICDR) Regulations, 2018. | – | – | No |